XTX-501

N/A

Report date: 2024/11/14 10:43:20

Base Information

Drug NameXTX-501

Drug Alias NameXTX-501XTX501

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionProgrammed cell death protein 1 modulatorsInterleukin-2 modulators

TargetsProgrammed cell death protein 1Interleukin-2

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesXilio Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesXilio Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A